Scientists from the Institute of Cancer Research (ICR) have found a new method for predicting bowel cancer risk in ...
Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
A new DNA test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer in the five years. People with inflammatory bowel disease (IBD) — which includes ...
Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback